Meanwhile, Microchip Biotechnologies of Fremont, California ... Micronics Inc., Boehringer-Ingelheim's MicroParts, Silicon Valley Scientific Inc., Microdrop and LICOM (Box 2).
Boehringer Ingelheim and Circle Pharma Announce New Research Collaboration to Develop a Novel Precision Cancer Treatment ...
Notable Labs’ attempts to take a Boehringer Ingelheim cancer drug to market appear to have come to end with the ...
Denmark's Zealand Pharma and German partner Boehringer Ingelheim have won the U.S. Food and Drug Administration's ...
Hosted by Boehringer Ingelheim, the ‘CRM Summit’, an expert engagement forum, and the ‘IMETA CRM Discussions for EXperts (MEDEX CRM)’, a scientific expert meeting, brought together healthcare ...
Find out how this could enhance access to quality healthcare, with an emphasis on mental health services for vulnerable populations.
GlobalData on MSN9d
Boehringer partners WHO Foundation to advance healthcare accessBoehringer Ingelheim, in partnership with the WHO Foundation [an organisation set up to support the World Health Organization ...
Boehringer Ingelheim says it is on track to launch 25 new treatments in its human pharma division onto the market between now and 2030, fuelled by an R&D pipeline that it says is the best in its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback